The present study shows that supplementation with CoQ10 or n-3 PUFAs had no appreciable effect on IH-induced VEGF during treatment, although the levels appeared to be lower with n-3 PUFAs. This evidence concerns the gene VEGFA and isolated hemihyperplasia.